NOVEL BENZIMIDAZOLE DERIVATIVES

Application 1893/KOLNP/2004 published 2006-11-03, filed 2004-12-09
The present invention relates to a compound of the formula (I) : (wherein A, B, C and D are independently nitrogen or optionally substituted methine; E is nitrogen, methine or hydroxy substituted methine; n is o or 1; T, U, V and W are independently nitrogen or optionally substituted methine; X is -N(SOZR4)-, N (COR5) - or -CO- ; Y is -C (R6) (R7) - , -O- or -N (RS) -, provided that the compound (I) when E is nitrogen, n is O, X is –CO-, and Y is –O- is excluded) and the like, which are useful as an agent for the treatment of various diseases related to NPY, for example cardiovascular disorders such as angina, acute or congestive heart failure, myocardial infarction, hypertension, nephropathy, electrolyte abnormality, vasospasm, arteriosclerosis, etc., central nervous system disorders such as bulimia, depression, anxiety, seizure, epilepsy, dementia, pain, alcoholism, drug withdrawal, circadian rhythm disorders, schizophrenia, memory impairment, sleep disorders, cognitive impairment, etc., metabolic diseases such as obesity, diabetes, hormone abnormality, hypercholesterolemia, hyperlipidemia, gout, fatty liver, etc., genital or reproductive disorders such as infertility, preterm labour, sexual dysfunction, etc., gastro-intestinal disorders, respiratory disorder, Inflammatory diseases or glaucoma, and the like, also for example, atherosclerosis, hypogonadism, hyperandrogenism, polycystic ovary syndrome (Pickwickian syndrome), hirsutism, gastro-intestinal motility disorder, obesity-related gastro-esophageal reflux, obesity hypoventilation, sleep apnea, inflammation, systemic inflammation of the vasculature, osteoarthritis, insulin resistance, bronchoconstriction, alcohol preference, metabolic syndriome, Alzheimer’s disease, cardiac hypertrophy, left ventricular hypertrophy, hypertriglyceridemia, low HDL cholesterol, cardiovascular disorders such as coronary heart disease (CHD), cerebrovascular disease, stroke, peripheral vascular disease, sudden death, gallbladder diseases, cancer (breast, endometrial, colon) breathlessness, hyperuricemia, impaired fertility, low back pain, or increased anesthetic risk, and the like. (FIG. Nil)

Applicant

BANYU PHARMACEUTICAL CO. LTD.
2-3 NIHOMBASHI HONCHO 2-CHOME, CHUO-KU, TOKYO 103-8416 JAPAN

Inventor

OTAKE NORIKAZU; MORIYA MINORU; OGINO YOSHIO; MATSUDA KENJI; NAGAE YOSHIKAZU; KANATANI AKIO; FUKAMI TAKEHIRO

International Info

Classification: C07D 471/04
Publication Number: WO 04/002986
Application Date: 2003-06-26

Priority Information

190978/2002 JAPAN 2002-06-28